1. Home
  2. MYSZ vs APVO Comparison

MYSZ vs APVO Comparison

Compare MYSZ & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.88

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$1.06

Market Cap

21.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
APVO
Founded
1999
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
21.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MYSZ
APVO
Price
$0.88
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
343.5K
1.1M
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,512,000.00
N/A
Revenue This Year
$29.71
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.04
52 Week High
$9.40
$298.00

Technical Indicators

Market Signals
Indicator
MYSZ
APVO
Relative Strength Index (RSI) 38.59 33.36
Support Level $0.96 $1.07
Resistance Level $0.96 $1.41
Average True Range (ATR) 0.08 0.09
MACD 0.00 -0.01
Stochastic Oscillator 2.86 13.86

Price Performance

Historical Comparison
MYSZ
APVO

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: